Anticoagulation for mechanical valve prostheses during pregnancy

Clinical Cardiology

Volumn 26, Issue 7, 2003, Pages 303-304

  Conti, C Richard ^a  

^a NONE

Author keywords

Anticoagulation; Pregnancy; Valve protheses

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULATION; BONE MALFORMATION; DRUG INDICATION; EDITORIAL; EMBRYOPATHY; FEMALE; FETUS RISK; HEART VALVE PROSTHESIS; HUMAN; HYPOPLASIA; NOSE HYPOPLASIA; NOSE MALFORMATION; PRACTICE GUIDELINE; PREGNANCY; RISK FACTOR; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT PLANNING; VERTEBRA MALFORMATION;

EID: 0038000601     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4950260702     Document Type: Editorial

References (7)

1. Naqvi TZ, Foster E: Anticoagulation during pregnancy. Curr Womens Health Rep 2002;2:95-104
2. Al-Lawati AA, Venkitraman M, Al-Delaime T, Valliathu J: Pregnancy and mechanical heart valve replacement: Dilemma of anticoagulation. Eur J Cardiothorac Surg 2002;22:223-227
3. Blickstein D, Blickstein L: The risk of fetal loss associated with warfarin anticoagulation. Int J Gynaecol Obstet 2002;78:221
4. Cotrufo M, De Feo M, De Santo LS, Romano G, Della Corte A, Renzulli A, Gallo C: Risk of warfarin during pregnancy with mechanical valve prostheses. Obstet Gynecol 2002;99(1):35-40
5. Chan WS, Anand S, Ginsberg JS: Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature. Arch Intern Med 2000;160(2):191-196
6. Warnes C, Somerville J: Valvular Disease in Pregnancy. ACCEL online. July 2002.
7. ACC/AHA Guidelines for the management of patients with valvular disease. J Amer Coll Cardiol 1998;32:1486-1582